Provided by Tiger Trade Technology Pte. Ltd.

Cogent Biosciences, Inc.

39.34
-0.2100-0.53%
Post-market: 38.27-1.0662-2.71%18:51 EST
Volume:2.12M
Turnover:83.21M
Market Cap:6.04B
PE:-15.94
High:39.94
Open:39.00
Low:38.31
Close:39.55
52wk High:43.73
52wk Low:3.72
Shares:153.51M
Float Shares:143.00M
Volume Ratio:0.65
T/O Rate:1.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4685
EPS(LYR):-2.4616
ROE:-95.40%
ROA:-47.47%
PB:31.04
PE(LYR):-15.98

Loading ...

Cogent Biosciences (COGT) Valuation After Positive APEX and SUMMIT Trial Results in Systemic Mastocytosis

Simply Wall St.
·
Dec 20

U.S. RESEARCH ROUNDUP-Carmax, Cintas, Nike

Reuters
·
Dec 19

Cogent Biosciences Says Bezuclastinib Showed 'Rapid and Deep Clinical Benefit' in Advanced Systemic Mastocytosis Trial

MT Newswires Live
·
Dec 08

BRIEF-Cogent Biosciences Announces Positive Top-Line Results Of APEX Trial Of Bezuclastinib In Patients With Advanced Systemic Mastocytosis

Reuters
·
Dec 08

Cogent Biosciences Inc - Bezuclastinib Trial Showed 89% of Patients Achieving ≥50% Reduction in Bone Marrow Mast Cells

THOMSON REUTERS
·
Dec 08

Cogent Biosciences Inc - Apex Nda Submission Expected in 1H 2026

THOMSON REUTERS
·
Dec 08

Cogent Biosciences Announces Positive Top-Line Results of Apex Trial of Bezuclastinib in Patients With Advanced Systemic Mastocytosis (Advsm)

THOMSON REUTERS
·
Dec 08

Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematology (ASH)

GlobeNewswire
·
Dec 06

U.S. RESEARCH ROUNDUP-Alignment Healthcare, BJ's Wholesale Club Holdings, Hyatt Hotels

Reuters
·
Nov 24

A Look at Cogent Biosciences’s Valuation After Positive Phase 3 Data and Major Funding Updates

Simply Wall St.
·
Nov 19

Cogent Biosciences Raises $230 Million Through Convertible Senior Notes Offering

Reuters
·
Nov 19

Cogent Biosciences (COGT) Gets a Buy from LifeSci Capital

TIPRANKS
·
Nov 15

BUZZ-Nasdaq biotech index hits record high, set to gain nearly 5% this week

Reuters
·
Nov 15

H.C. Wainwright Reaffirms Their Buy Rating on Cogent Biosciences (COGT)

TIPRANKS
·
Nov 13

Cogent Biosciences Expects $547 Million in Net Proceeds From Equity, Convertible Notes Offerings

MT Newswires Live
·
Nov 13

Cogent Biosciences Inc - Enters Underwriting Agreement With Jefferies, J.p. Morgan Llc - SEC Filing

THOMSON REUTERS
·
Nov 13

Cogent Biosciences Inc - to Issue $200 Mln of 1.625% Convertible Notes Due 2031 - SEC Filing

THOMSON REUTERS
·
Nov 13

BUZZ-U.S. STOCKS ON THE MOVE-Floor & Decor, Starbucks, gold miners

Reuters
·
Nov 12

Cogent Biosciences Inc : JP Morgan Raises Target Price to $65 From $44

THOMSON REUTERS
·
Nov 12

BUZZ-U.S. STOCKS ON THE MOVE-ExxonMobil, Yatra, Venture Global

Reuters
·
Nov 12